Nautilus Biotechnology Inc
NAUT
Get informed when a big investor buys or sells
+ FollowMarket Cap$122.51M
Close$
$-0.14
114.5% downside
Current Fair Value
114.5% downsideOvervalued by 114.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $122.51 Million |
|---|---|
| Enterprise Value | $137.16 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.47 |
| Beta | 0.87 |
| Outstanding Shares | 126,886,646 |
Return
| Return on Equity | -43.11% |
|---|---|
| Return on Assets | -34.55% |
| Return on Invested Capital | -38.24% |
Valuation & Multiples
| P/E Ratio | -2.14 |
|---|---|
| PEG | 57.02 |
| Price to Sales | - |
| Price to Book Ratio | 0.96 |
| Enterprise Value to Revenue | 721.89 |
| Enterprise Value to EBIT | -2.32 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.2 |
| Debt to Equity | 0.21 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 4, 2026
EPS Estimate
$-0.14
Average shareholder expectationRevenue Estimate
$250,000
Average shareholder expectationNext Earnings Call
Expected Date
October 27, 2026
EPS Estimate
$-0.14
Average shareholder expectationRevenue Estimate
$208,333
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.0532▲ 105.32% |
|---|---|
| Total Calls | 18,800▼ 69.53% |
| Total Puts | 19,800▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 39.62%▼ 3.29% |
|---|---|
| Total Invested | $93.94M▼ 55.44% |
| Investors Holding | 95▲ 14.00% |
ESG Score
No data